Literature DB >> 34224301

Roles of cytochrome P450 2A6 in the oxidation of flavone, 4'-hydroxyflavone, and 4'-, 3'-, and 2'-methoxyflavones by human liver microsomes.

Haruna Nagayoshi1, Norie Murayama2, Shigeo Takenaka3, Vitchan Kim4, Donghak Kim4, Masayuki Komori5, Hiroshi Yamazaki2, F Peter Guengerich6, Tsutomu Shimada3,5.   

Abstract

Nine forms of recombinant cytochrome P450 (P450 or CYP) enzymes were used to study roles of individual P450 enzymes in the oxidation of flavone and some other flavonoids, 4'-hydroxyflavone and 4'-, 3'-, and 2'-methoxyflavones, by human liver microsomes using LC-MS/MS analysis.As has been reported previously , 4'-, 3'-, and 2'-methoxyflavones were preferentially O-demethylated by human liver P450 enzymes to form 4'-, 3'-, and 2'-hydroxylated flavones and also 3',4'-dihydroxyflavone from the former two substrates.In comparisons of product formation by oxidation of these methoxylated flavones, CYP2A6 was found to be a major enzyme catalysing flavone 4'- and 3'-hydroxylations by human liver microsomes but did not play significant roles in 2'-hydroxylation of flavone, O-demethylations of three methoxylated flavones, and the oxidation of 4'-hydroxyflavone to 3',4'-dihydroxyflavone.The effects of anti-CYP2A6 IgG and chemical P450 inhibitors suggested that different P450 enzymes, as well as CYP2A6, catalysed oxidation of these flavonoids at different positions by liver microsomes.These studies suggest that CYP2A6 catalyses flavone 4'- and 3'-hydroxylations in human liver microsomes and that other P450 enzymes have different roles in oxidizing these flavonoids.

Entities:  

Keywords:  3′- and 4′-hydroxylation; CYP2A6; Flavone; LC-MS/MS; flavonoids; human liver

Mesh:

Substances:

Year:  2021        PMID: 34224301      PMCID: PMC8719450          DOI: 10.1080/00498254.2021.1950866

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  40 in total

1.  In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10.

Authors:  Vitchan Kim; Sora Yeom; Yejin Lee; Hyoung-Goo Park; Myung-A Cho; Harim Kim; Donghak Kim
Journal:  J Toxicol Environ Health A       Date:  2018-04-13

2.  Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3',4'-dihydroxyflavone and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity.

Authors:  Doreen Schlupper; Sabine Giesa; Rolf Gebhardt
Journal:  Planta Med       Date:  2006-05-29       Impact factor: 3.352

3.  Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35).

Authors:  Songhee Han; Seunghye Choi; Young-Jin Chun; Chul-Ho Yun; Chang Hoon Lee; Hee Jung Shin; Han Sung Na; Myeon Woo Chung; Donghak Kim
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

4.  Specificity of 17beta-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432.

Authors:  T Shimada; J Watanabe; K Inoue; F P Guengerich; E M Gillam
Journal:  Xenobiotica       Date:  2001-03       Impact factor: 1.908

5.  Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein.

Authors:  Shuzhong Zhang; Xinning Yang; Robert A Coburn; Marilyn E Morris
Journal:  Biochem Pharmacol       Date:  2005-08-15       Impact factor: 5.858

6.  Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  T Su; Z Bao; Q Y Zhang; T J Smith; J Y Hong; X Ding
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

7.  Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants.

Authors:  Tsutomu Shimada; Norie Murayama; Kensaku Kakimoto; Shigeo Takenaka; Young-Ran Lim; Sora Yeom; Donghak Kim; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Xenobiotica       Date:  2017-07-21       Impact factor: 1.908

8.  Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids.

Authors:  Tomohide Uno; Chika Ogura; Chiho Izumi; Masahiko Nakamura; Takeshi Yanase; Hiroshi Yamazaki; Hitoshi Ashida; Kengo Kanamaru; Hiroshi Yamagata; Hiromasa Imaishi
Journal:  Biopharm Drug Dispos       Date:  2015-08-31       Impact factor: 1.627

9.  Site-specific oxidation of flavanone and flavone by cytochrome P450 2A6 in human liver microsomes.

Authors:  Haruna Nagayoshi; Norie Murayama; Kensaku Kakimoto; Shigeo Takenaka; Jun Katahira; Young-Ran Lim; Vitchan Kim; Donghak Kim; Hiroshi Yamazaki; Masayuki Komori; F Peter Guengerich; Tsutomu Shimada
Journal:  Xenobiotica       Date:  2018-09-28       Impact factor: 1.908

10.  Synthetic 3',4'-Dihydroxyflavone Exerts Anti-Neuroinflammatory Effects in BV2 Microglia and a Mouse Model.

Authors:  Namkwon Kim; Hyung-Seok Yoo; Yeon-Joo Ju; Myung Sook Oh; Kyung-Tae Lee; Kyung-Soo Inn; Nam-Jung Kim; Jong Kil Lee
Journal:  Biomol Ther (Seoul)       Date:  2018-03-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.